Western is entering into the detailed design phase for the Bioconvergence Centre, a 375,000-square-foot facility that will transform health research and science and medical education.
Among the largest capital projects in Western’s history, the state-of-the-art interdisciplinary research space will advance one of the university’s core strengths—biotherapeutics research and development—drawing on expertise across medicine, the biomedical and life sciences and engineering. It will serve as a hub for interdisciplinary teams from Schulich School of Medicine & Dentistry and the Faculties of Engineering, Health Sciences and Science, and will also include laboratory and instructional space for Schulich’s MD program and new chemistry labs.
From developing wearable diagnostics to precision cancer therapies—future physicians, engineers, scientists and other experts will learn and discover within this shared environment designed to foster collaboration.
“This is not just a building—it’s a transformational investment in our future,” says Western President Alan Shepard. “The Bioconvergence Centre will bring together brilliant minds across fields to drive health advancements for Canada and beyond.”
Pending approval from Western’s Board of Governors, construction is expected to begin in early 2027, with the building slated to open in 2031.
